Ekso Bionics Announces Third Quarter 2024 Financial Results

SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2024. Recent Highlights and Accomplishments Reported revenue of $4.1 million in the third quarter of 2024 Sold a total of 33 EksoHealth devices in the third quarter of 2024 Announced receipt of initial Centers for Medicare & Medicaid Serv ...